Eosinophils in the pathogenesis of allergic airways disease

被引:109
作者
Trivedi, S. G. [1 ]
Lloyd, C. M. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Leukocyte Biol Sect, London SW7 2AZ, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
eosinophil; asthma; airway hyper-responsiveness; remodelling;
D O I
10.1007/s00018-007-6527-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Eosinophils are traditionally thought to form part of the innate immune response against parasitic helminths acting through the release of cytotoxic granule proteins. However, they are also a central feature in asthma. From their development in the bone marrow to their recruitment to the lung via chemokines and cytokines, they form an important component of the inflammatory milieu observed in the asthmatic lung following allergen challenge. A wealth of studies has been performed in both patients with asthma and in mouse models of allergic pulmonary inflammation to delineate the role of eosinophils in the allergic response. Although the long-standing association between eosinophils and the induction of airway hyper-responsiveness remains controversial, recent studies have shown that eosinophils may also promote airway remodelling. In addition, emerging evidence suggests that the eosinophil may also serve to modulate the immune response. Here we review the highly co-ordinated nature of eosinophil development and trafficking and the evolution of the eosinophil as a multi-factoral leukocyte with diverse functions in asthma.
引用
收藏
页码:1269 / 1289
页数:21
相关论文
共 205 条
[31]   Airway remodeling in asthma [J].
Elias, JA ;
Zhu, Z ;
Chupp, G ;
Homer, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (08) :1001-1006
[32]   EXPRESSION OF TRANSFORMING GROWTH FACTORS-ALPHA AND BETA(1) MESSENGER-RNA AND PRODUCT BY EOSINOPHILS IN NASAL POLYPS [J].
ELOVIC, A ;
WONG, DTW ;
WELLER, PF ;
MATOSSIAN, K ;
GALLI, SJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (05) :864-869
[33]   Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways [J].
Erjefält, JS ;
Greiff, L ;
Andersson, M ;
Matsson, E ;
Petersen, H ;
Linden, M ;
Ansari, T ;
Jeffery, PK ;
Persson, CGA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (01) :304-312
[34]   New aspects of degranulation and fates of airway mucosal eosinophils [J].
Erjefält, JS ;
Persson, CGA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (06) :2074-2085
[35]   Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease [J].
Erjefält, JS ;
Greiff, L ;
Andersson, M ;
Ädelroth, E ;
Jeffery, PK ;
Persson, CGA .
THORAX, 2001, 56 (05) :341-344
[36]  
Fine Alan, 1993, Regional Immunology, V5, P218
[37]   Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics [J].
Flood-Page, P ;
Menzies-Gow, A ;
Phipps, S ;
Ying, S ;
Wangoo, A ;
Ludwig, MS ;
Barnes, N ;
Robinson, D ;
Kay, AB .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (07) :1029-1036
[38]   Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes [J].
Forssmann, U ;
Uguccioni, M ;
Loetscher, P ;
Dahinden, CA ;
Langen, H ;
Thelen, M ;
Baggiolini, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (12) :2171-2176
[39]   Elemental signals regulating eosinophil accumulation in the lung [J].
Foster, PS ;
Mould, AW ;
Yang, M ;
Mackenzie, J ;
Mattes, J ;
Hogan, SP ;
Mahalingam, S ;
McKenzie, ANJ ;
Rothenberg, ME ;
Young, IG ;
Matthaei, KI ;
Webb, DC .
IMMUNOLOGICAL REVIEWS, 2001, 179 :173-181
[40]   Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model [J].
Foster, PS ;
Hogan, SP ;
Ramsay, AJ ;
Matthaei, KI ;
Young, IG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :195-201